10.3 Million People Infected by Measles in 2023

Nov. 15, 2024
New data from the World Health Organization and the U.S. Centers for Disease Control and Prevention finds that inadequate immunization globally is driving the increase in cases.

According to a Nov. 14 press release, globally, there were an estimated 10.3 million cases of measles in 2023, a 20% increase from 2022, according to new estimates from the World Health Organization (WHO) and the U.S. Centers for Disease Control and Prevention (CDC).

The press release notes that inadequate immunization coverage globally is driving the surge in cases.

The press release said, “Measles is preventable with two doses of the measles vaccine; yet more than 22 million children missed their first dose of the measles vaccine in 2023. Globally, an estimated 83% of children received their first dose of measles vaccine last year, while only 74% received the recommended second dose.”

Further, “Coverage of 95% or greater of two doses of measles vaccine is needed in each country and community to prevent outbreaks and protect populations from one of the world's most contagious human viruses.”

"Measles vaccine has saved more lives than any other vaccine in the past 50 years," said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. "To save even more lives and stop this deadly virus from harming the most vulnerable, we must invest in immunization for every person, no matter where they live."

"The number of measles infections are rising around the globe, endangering lives and health," CDC Director Mandy Cohen said. "The measles vaccine is our best protection against the virus, and we must continue to invest in efforts to increase access."

Resulting from global gaps in vaccination coverage, 57 countries experienced large or disruptive measles outbreaks in 2023, affecting all regions except the Americas, and representing a nearly 60% increase from 36 countries in the previous year. The WHO African, Eastern Mediterranean, European, Southeast Asia and Western Pacific regions experienced a substantial upsurge in cases. Nearly half of all large or disruptive outbreaks occurred in the African region.

“The new data show that an estimated 107,500 people, mostly children younger than 5 years of age, died due to measles in 2023,” the release added. “Although this is an 8% decrease from the previous year, far too many children are still dying from this preventable disease. This slight reduction in deaths was mainly because the surge in cases occurred in countries and regions where children with measles are less likely to die, due to better nutritional status and access to health services.”

Surviving measles can cause serious, sometimes lifelong, health effects. Infants and young children are at the greatest risk of serious complications like blindness, pneumonia, and encephalitis.

The release goes on to say that “As measles cases surge and outbreaks increase, the world's elimination goal, as laid out in Immunization Agenda 2030, is under threat. Worldwide, 82 countries had achieved or maintained measles elimination at the end of 2023. This week, Brazil was reverified as having eliminated measles, making the WHO Americas Region once again free of endemic measles. With the exception of the African Region, at least one country in all WHO regions has eliminated the disease.”

Indeed, “Urgent and targeted efforts by countries and partners, particularly in the African and Eastern Mediterranean regions, and in fragile, conflict-affected, and vulnerable settings, are needed to vaccinate all children fully with two doses of measles vaccine. This requires achieving and maintaining high-performing routine immunization programs and delivering high-quality, high-coverage campaigns when those programs are not yet sufficient to protect every child.”

Countries and global immunization partners are urged in the press release to also strengthen disease surveillance, including the Global Measles Rubella Laboratory Network (GMRLN). Strong disease surveillance is key to optimizing immunization programs and detecting and responding rapidly to measles outbreaks to mitigate their size and impact.

About the Author

Janette Wider | Editor-in-Chief

Janette Wider is Editor-in-Chief for Healthcare Purchasing News.